<SUBMISSION>
<ACCESSION-NUMBER>0000950148-02-001582
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>2
<PERIOD>20020621
<ITEMS>5
<ITEMS>7
<FILING-DATE>20020621
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ADVANCED BIOTHERAPY INC
<CIK>0000791833
<ASSIGNED-SIC>8731
<STATE-OF-INCORPORATION>NV
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-26323
<FILM-NUMBER>02684332
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>6355 TOPANGA CANYON BLVD
<STREET2>SUITE 510
<CITY>WOODLAND HILLS
<STATE>CA
<ZIP>91367
<PHONE>8188833956
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>6355 TOPANGA CANYON BLVD
<STREET2>SUITE 510
<CITY>WOODLAND HILLS
<STATE>CA
<ZIP>91367
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>ADVANCED BIOTHERAPY CONCEPTS INC
<DATE-CHANGED>19990524
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v82557e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>Advanced Biotherapy, Inc., 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<P align="center"><FONT size="2"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, DC 20549</B></FONT>

<P align="center"><FONT size="2"><B>FORM 8-K</B></FONT>

<P align="center"><FONT size="2"><B>CURRENT REPORT<br>
  </B></FONT><FONT size="2"><FONT size="3"><B>Pursuant to Section&nbsp;13 or 15(d)
  of the Securities Exchange Act of 1934</B></FONT></FONT>
<P><FONT size="2">Date of Report (Date of earliest reported) June&nbsp;21, 2002
</FONT>
<P align="center"><FONT size="2">Advanced Biotherapy, Inc.</FONT>
<HR width="300" align="center" size="1" noshade>
<div align="center"><FONT size="2">(Exact name of registrant as specified in its
  chapter)</FONT> </div>
<CENTER>
  <TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
    <TR valign="bottom">
      <TD width="30%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="30%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="30%">&nbsp;</TD>
    </TR>
    <TR valign="bottom">
      <TD nowrap align="center"><font size="2">Delaware</font></TD>
      <TD><font size="2">&nbsp;</font></TD>
      <TD nowrap align="center"><font size="2">0-26323</font></TD>
      <TD><font size="2">&nbsp;</font></TD>
      <TD nowrap align="center"><font size="2">95-0402415</font></TD>
    </TR>
    <TR valign="bottom">
      <TD nowrap align="center">
        <HR size="1" noshade>
      </TD>
      <TD><FONT size="1">&nbsp;</FONT></TD>
      <TD nowrap align="center">
        <HR size="1" noshade>
      </TD>
      <TD><FONT size="1">&nbsp;</FONT></TD>
      <TD nowrap align="center">
        <HR size="1" noshade>
      </TD>
    </TR>
    <TR valign="bottom">
      <TD align="center" valign="top"><FONT size="2">(State or other jurisdiction</FONT></TD>
      <TD><FONT size="2">&nbsp;</FONT></TD>
      <TD align="center" valign="top"><FONT size="2"> (Commission </FONT></TD>
      <TD><FONT size="2">&nbsp;</FONT></TD>
      <TD align="center" valign="top"><FONT size="2">(IRS Employer</FONT></TD>
    </TR>
    <TR valign="bottom">
      <TD align="center" valign="top"><FONT size="2">of incorporation)</FONT></TD>
      <TD><FONT size="2">&nbsp;</FONT></TD>
      <TD align="center" valign="top"><FONT size="2"> File Number) </FONT></TD>
      <TD><FONT size="2">&nbsp;</FONT></TD>
      <TD align="center" valign="top"><FONT size="2">Identification No.)</FONT></TD>
    </TR>
  </TABLE>
</CENTER>
<CENTER>
  <TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
    <TR valign="bottom">
      <TD width="51%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="44%">&nbsp;</TD>
    </TR>
    <TR valign="bottom">
      <TD nowrap align="center">
        <div align="left"><font size="2">6355 Topanga Canyon Boulevard, Suite
          510<BR>
Woodland Hills, California</font></div>
      </TD>
      <TD><font size="2">&nbsp;</font></TD>
      <TD nowrap align="center"><font size="2">91367</font></TD>
    </TR>
    <TR valign="bottom">
      <TD nowrap align="center">
        <HR size="1" noshade align="left">
      </TD>
      <TD><FONT size="1">&nbsp;</FONT></TD>
      <TD nowrap align="center">
        <HR size="1" noshade>
      </TD>
    </TR>

    <TR valign="bottom">
      <TD align="center" valign="top">
        <div align="left"><FONT size="2">(Address of principal executive offices)</FONT> </div>
      </TD>
      <TD><FONT size="2">&nbsp;</FONT></TD>
      <TD align="center" valign="top">
        <DIV style="margin-left:10px; text-indent:-10px"><FONT size="2"> (Zip
          Code)</FONT></DIV>
      </TD>
    </TR>
    <TR valign="bottom">
      <TD align="center" valign="top">
        <div align="left"><FONT size="2">&nbsp;</FONT>
        </div>
      </TD>
      <TD><FONT size="2">&nbsp;</FONT></TD>
      <TD align="center" valign="top">
        <DIV style="margin-left:10px; text-indent:-10px"></DIV>
      </TD>
    </TR>
  </TABLE>
</CENTER>
<P><FONT size="2">Registrant&#146;s telephone number, including area code (818)&nbsp;883-6716
</FONT>
<P align="center"><FONT size="2">&nbsp;
</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD></TD><TD colspan="8"><A HREF="#000">Item&nbsp;5. OTHER EVENTS.</A></TD></TR>
<TR><TD></TD><TD colspan="8"><A HREF="#001">Item&nbsp;7. FINANCIAL STATEMENTS AND EXHIBITS</A></TD></TR>
<TR><TD colspan="9"><A HREF="#002"> Signatures</A></TD></TR>
<TR><TD colspan="9"><A HREF="#003">INDEX TO EXHIBITS</A></TD></TR>
<TR><TD colspan="9"><A HREF="v82557exv99w1.htm">EXHIBIT 99.1</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<!-- link2 "Item&nbsp;5. OTHER EVENTS." -->
<DIV align="left"><A NAME="000"></A></DIV>
<P align="left"><FONT size="2">Item&nbsp;5. OTHER EVENTS.</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The registrant published a press release on June&nbsp;20, 2002, which reported
that its Chief Executive Officer and President, Mr.&nbsp;Edmond Buccellato, was
interviewed by the Wall Street Reporter. The content of that interview is
available to be heard for approximately one week by logging-in at
www.wallstreetreporter.com under &#147;CEO Interviews.&#148;
</FONT>
<!-- link2 "Item&nbsp;7. FINANCIAL STATEMENTS AND EXHIBITS" -->
<DIV align="left"><A NAME="001"></A></DIV>
<P align="left"><FONT size="2">Item&nbsp;7. FINANCIAL STATEMENTS AND EXHIBITS</FONT>

<P><FONT size="2">(c)&nbsp;Exhibits.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="27%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="68%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD valign="top"><FONT size="2">Designation</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Description of Exhibit</FONT></TD>
</TR>

<TR valign="bottom">
        <TD valign="top"><FONT size="2">99.1</FONT></TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Press Release, dated June&nbsp;20, 2002</FONT></TD>
</TR>
</TABLE>
</CENTER>
<!-- link1 " Signatures" -->
<DIV align="left"><A NAME="002"></A></DIV>
<P align="center"><FONT size="2">Signatures</FONT>
<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
</FONT>
<CENTER>
  <TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
    <TR valign="bottom">
      <TD width="50%">&nbsp;</TD>
      <TD width="5%">&nbsp;</TD>
      <TD width="45%">&nbsp;</TD>
    </TR>
    <TR valign="bottom">
      <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
      <TD colspan="2"><FONT size="2"> ADVANCED BIOTHERAPY,
        INC. <br>
        (Registrant)</FONT></TD>
    </TR>
    <TR valign="bottom">
      <TD valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
    </TR>
    <TR valign="bottom">
      <TD valign="top">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD align="left" valign="top">&nbsp;</TD>
    </TR>
    <TR valign="bottom">
      <TD><FONT size="2">Date: June&nbsp;21, 2002</FONT></TD>
      <TD><FONT size="2">&nbsp;</FONT></TD>
      <TD align="left"><FONT size="2"> By: /s/&nbsp;Edmond Buccellato</FONT></TD>
    </TR>
    <TR>
      <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
      <TD><FONT size="2">&nbsp;</FONT></TD>
      <TD align="left" valign="top" rowspan="2"><FONT size="2">
        <HR size="1" noshade>
        </FONT><FONT size="2"> Edmond Buccellato, President and CEO</FONT></TD>
    </TR>
    <TR valign="bottom">
      <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
      <TD><FONT size="2">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
</CENTER>
<!-- link1 "INDEX TO EXHIBITS" -->
<DIV align="left"><A NAME="003"></A></DIV>
<P align="center"><FONT size="2">INDEX TO EXHIBITS</FONT>

<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
        <TD width="10%">&nbsp;</TD>
        <TD width="5%">&nbsp;</TD>
        <TD width="85%">&nbsp;</TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><FONT size="1">Exhibit</FONT></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center">
        <div align="left"><FONT size="1">Description</FONT></div>
      </TD>
</TR>
<TR valign="bottom">
        <TD nowrap align="center"><HR size="1" noshade></TD>
        <TD><FONT size="1">&nbsp;</FONT></TD>
        <TD nowrap align="center"><HR size="1" noshade></TD>
</TR>
<TR valign="bottom">
        <TD valign="top">
        <div align="center"><FONT size="2">99.1</FONT></div>
      </TD>
        <TD><FONT size="2">&nbsp;</FONT></TD>
        <TD align="left" valign="top"><FONT size="2">
Text of Press Release, dated June&nbsp;20, 2002</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;
</FONT>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>v82557exv99w1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>Advanced Biotherapy, Inc., Exhibit 99.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P><FONT size="2">EXHIBIT 99.1
</FONT>
<P align="left"><FONT size="2"><B>Advanced Biotherapy, Inc.&#146;s CEO Interviewed by The Wall Street Reporter</B></FONT>

<P><FONT size="2">WOODLAND HILLS, Calif.&nbsp;&#151; (BW HealthWire)&nbsp;&#151; June&nbsp;20, 2002&nbsp;&#151; Advanced Biotherapy,
Inc. (OTCBB:ADVB) reported today that its Chief Executive officer and
president, Mr.&nbsp;Edmond Buccellato, was interviewed by the Wall Street Reporter
at 12:15 pacific time today. The content of that interview can be heard after
logging-in at www.wallstreetreporter.com under &#147;CEO Interviews.&#148;
</FONT>
<P><FONT size="2">As previously reported, the United States Patent and Trademark Office (USPTO)
issued U.S. Patent No.&nbsp;6,333,032 to the Company for the exclusive use of
antibodies to gamma interferon &#151; including humanized and fully human, as well
as other antibody types &#151; to treat Multiple Sclerosis, Rheumatoid Arthritis,
Juvenile Rheumatoid Arthritis, Psoriatic Arthritis (a form of psoriasis) and
Ankylosing Spondylitis. The Company also has patent applications pending for
the exclusive use of any form of antibodies to gamma interferon &#151; including
humanized and fully human &#151; for the treatment of Crohn&#146;s Disease, Psoriasis,
Vitiligo, Alopecia Areata and Hyperimmune Response in the Eye, among other
patents pending.
</FONT>
<P><FONT size="2">The Company does not control the Wall Street Reporter website, nor does it
control the content of the audio portion of Mr.&nbsp;Buccellato&#146;s interview, nor
does it warrant the accuracy, integrity or completeness of such interview as
reproduced or the audio portion thereof. The Company makes no warranty that any
content on the Wall Street Reporter website will be received by you as
uninterrupted, timely, secure, or error-free.
</FONT>
<P><FONT size="2">Statements made in this news release, other than statements of historical fact,
are forward-looking statements and are subject to a number of uncertainties
that could cause actual results to differ materially from the anticipated
results or other expectations expressed in our forward-looking statements. The
risks and uncertainties that may affect the development, operations and results
of our business include, but are not limited to, the following: risks
associated with clinical trials, the uncertainties of research and product
development programs, the uncertainties of the regulatory approval process, the
risks of competitive products, the risks of our current capital resources, the
uncertainties as to the availability of future capital and our future capital
requirements, and the risks associated with the extent and breadth of the
Company&#146;s patent portfolio. The foregoing discussion of the effect of the
patents issued and pending involves risks and uncertainties, including, but not
limited to, the risks that third parties may be successful in challenging such
patents; or that granted claims may be held invalid or interpreted differently
by a court of law; or that new technologies will be developed that are superior
in treating the diseases targeted by Advanced Biotherapy, Inc. Readers are
cautioned not to place reliance on these forward-looking statements, which
speak only as of the date the statements were made. See the Company&#146;s public
filings with the Securities and Exchange Commission for further information
about risks and uncertainties that may affect the Company and the results or
expectations expressed in our forward-looking statements, including the section
captioned &#147;Factors That May Affect The Company&#148; contained in the Company&#146;s
Annual Report on Form&nbsp;10-KSB for the fiscal year ended December&nbsp;31, 2001.
</FONT>
<P><FONT size="2">CONTACT:
</FONT>
<P><FONT size="2">Advanced Biotherapy Inc., Woodland Hills
</FONT>
<P><FONT size="2">Edmond Buccellato, 818/883-6716, ext. 2
</FONT>
<P><FONT size="2">E-mail: ed@advancedbiotherapy.com
</FONT>
<P><FONT size="2">Website: www.advancedbiotherapy.com
</FONT>
<P><FONT size="2">SOURCE: Advanced Biotherapy Inc.
</FONT>

<P align="center"><FONT size="2">&nbsp;</FONT>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
</SUBMISSION>
